Current Report Filing (8-k)
March 17 2014 - 5:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(D) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 10, 2014
Competitive Technologies, Inc. |
(Exact name of registrant as specified in its charter) |
Delaware |
001-08696 |
36-2664428 |
(State or other jurisdiction
of incorporation) |
(Commission File Number) |
(IRS Employer
Identification No.) |
1375 Kings Highway East, Fairfield, Connecticut |
06824 |
(Address of principal executive offices) |
(Zip Code) |
Registrant's telephone number, including
area code: (203) 368-6044
N/A |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On February 10, 2014, pursuant to an unanimous
written consent of the board of the directors in lieu of a special meeting (the “Board Resolution”), Competitive Technologies,
Inc.’s board of directors (the “Board”) determined that Mr. Johnnie Johnson (“Johnson”) may have
acted contrary to the best interests of Competitive Technologies, Inc. (the “Company”) and its stockholders in connection
to certain contracts, agreements, initiatives or other actions Johnson entered into on behalf of the Company without obtaining
the Board’s approval (the “Actions”) and may have breached fiduciary duties owed to the Company and its stockholders
under Delaware law during his employment as the Chief Financial Officer and consultant for the Company.
To protect the best interest of the Company
and its stockholders, the Board further determined that Johnson did not have the authority to act on behalf of the Company in connection
to the Actions and rendered such Actions rejected, null and void. The Board also authorized certain officers to take all measures
appropriate and necessary to nullify the Actions.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Competitive Technologies, Inc. |
|
|
|
Date: March 17, 2014 |
By: |
/s/ Conrad Mir |
|
|
Name: Conrad Mir |
|
|
Title: Chief Executive Officer |
Calmare Therapeutics (CE) (USOTC:CTTC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Calmare Therapeutics (CE) (USOTC:CTTC)
Historical Stock Chart
From Apr 2023 to Apr 2024